Stimulation of calcitonin secretion by calcium receptor activators: Evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin

Jeffrey R. Lavigne, Richard J. Zahradnik, Rebecca L. Conklin, Lyssa D. Lambert, Mary Logan, Ashutosh Parihar, John Fox

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Current rat calcitonin immunoassays use human calcitonin antisera, and suffer from poor sensitivity, long incubation periods, nonspecific interferences, and unreliability. The homologous immunoradiometric assay (IRMA) for rat calcitonin described here overcomes these problems. Overnight incubation yields a detection limit of 0.4 pg/mL, a standard curve that is linear to >1800 pg/mL, and intra- and interassay coefficients of variation of 2+ concentration or incubation with the calcimimetic compound NPS R-467 markedly increased calcitonin secretion. Plasma calcitonin levels were elevated in rats anesthetized with ketamine/xylazine and in conscious rats with chronic renal insufficiency. Calcitonin levels decreased following EGTA- induced hypocalcemia and were undetectable after thyroparathyroidectomy. In normal conscious rats, plasma calcitonin levels averaged 3-5 pg/mL and increased up to 100-fold following calcium (Ca) infusion or NPS R-467 administration. The assay also quantified calcitonin in plasma of normal and Ca-injected mice. This assay has revealed that plasma calcitonin levels in normal rats are much lower than the detection limits of most existing assays, but can increase by 100-fold on activation of the C-cell Ca 2+ receptor.

Original languageEnglish (US)
Pages (from-to)293-301
Number of pages9
JournalEndocrine
Volume9
Issue number3
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Immunoradiometric Assay
Calcium-Sensing Receptors
Calcitonin
Limit of Detection
Calcium
Xylazine
Hypocalcemia
Egtazic Acid
Ketamine
Chronic Renal Insufficiency
Immunoassay
Immune Sera

Keywords

  • Calcimimetics
  • Calcitonin
  • Immunoradiometric assay
  • Rat
  • Rat medullary thyroid carcinoma 44-2 cells

ASJC Scopus subject areas

  • Endocrinology

Cite this

Stimulation of calcitonin secretion by calcium receptor activators : Evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin. / Lavigne, Jeffrey R.; Zahradnik, Richard J.; Conklin, Rebecca L.; Lambert, Lyssa D.; Logan, Mary; Parihar, Ashutosh; Fox, John.

In: Endocrine, Vol. 9, No. 3, 1998, p. 293-301.

Research output: Contribution to journalArticle

Lavigne, Jeffrey R. ; Zahradnik, Richard J. ; Conklin, Rebecca L. ; Lambert, Lyssa D. ; Logan, Mary ; Parihar, Ashutosh ; Fox, John. / Stimulation of calcitonin secretion by calcium receptor activators : Evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin. In: Endocrine. 1998 ; Vol. 9, No. 3. pp. 293-301.
@article{e425da2e734f4525ab1f21706933bc29,
title = "Stimulation of calcitonin secretion by calcium receptor activators: Evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin",
abstract = "Current rat calcitonin immunoassays use human calcitonin antisera, and suffer from poor sensitivity, long incubation periods, nonspecific interferences, and unreliability. The homologous immunoradiometric assay (IRMA) for rat calcitonin described here overcomes these problems. Overnight incubation yields a detection limit of 0.4 pg/mL, a standard curve that is linear to >1800 pg/mL, and intra- and interassay coefficients of variation of 2+ concentration or incubation with the calcimimetic compound NPS R-467 markedly increased calcitonin secretion. Plasma calcitonin levels were elevated in rats anesthetized with ketamine/xylazine and in conscious rats with chronic renal insufficiency. Calcitonin levels decreased following EGTA- induced hypocalcemia and were undetectable after thyroparathyroidectomy. In normal conscious rats, plasma calcitonin levels averaged 3-5 pg/mL and increased up to 100-fold following calcium (Ca) infusion or NPS R-467 administration. The assay also quantified calcitonin in plasma of normal and Ca-injected mice. This assay has revealed that plasma calcitonin levels in normal rats are much lower than the detection limits of most existing assays, but can increase by 100-fold on activation of the C-cell Ca 2+ receptor.",
keywords = "Calcimimetics, Calcitonin, Immunoradiometric assay, Rat, Rat medullary thyroid carcinoma 44-2 cells",
author = "Lavigne, {Jeffrey R.} and Zahradnik, {Richard J.} and Conklin, {Rebecca L.} and Lambert, {Lyssa D.} and Mary Logan and Ashutosh Parihar and John Fox",
year = "1998",
doi = "10.1385/ENDO:9:3:293",
language = "English (US)",
volume = "9",
pages = "293--301",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Stimulation of calcitonin secretion by calcium receptor activators

T2 - Evaluation using a new, highly sensitive, homologous immunoradiometric assay for rat calcitonin

AU - Lavigne, Jeffrey R.

AU - Zahradnik, Richard J.

AU - Conklin, Rebecca L.

AU - Lambert, Lyssa D.

AU - Logan, Mary

AU - Parihar, Ashutosh

AU - Fox, John

PY - 1998

Y1 - 1998

N2 - Current rat calcitonin immunoassays use human calcitonin antisera, and suffer from poor sensitivity, long incubation periods, nonspecific interferences, and unreliability. The homologous immunoradiometric assay (IRMA) for rat calcitonin described here overcomes these problems. Overnight incubation yields a detection limit of 0.4 pg/mL, a standard curve that is linear to >1800 pg/mL, and intra- and interassay coefficients of variation of 2+ concentration or incubation with the calcimimetic compound NPS R-467 markedly increased calcitonin secretion. Plasma calcitonin levels were elevated in rats anesthetized with ketamine/xylazine and in conscious rats with chronic renal insufficiency. Calcitonin levels decreased following EGTA- induced hypocalcemia and were undetectable after thyroparathyroidectomy. In normal conscious rats, plasma calcitonin levels averaged 3-5 pg/mL and increased up to 100-fold following calcium (Ca) infusion or NPS R-467 administration. The assay also quantified calcitonin in plasma of normal and Ca-injected mice. This assay has revealed that plasma calcitonin levels in normal rats are much lower than the detection limits of most existing assays, but can increase by 100-fold on activation of the C-cell Ca 2+ receptor.

AB - Current rat calcitonin immunoassays use human calcitonin antisera, and suffer from poor sensitivity, long incubation periods, nonspecific interferences, and unreliability. The homologous immunoradiometric assay (IRMA) for rat calcitonin described here overcomes these problems. Overnight incubation yields a detection limit of 0.4 pg/mL, a standard curve that is linear to >1800 pg/mL, and intra- and interassay coefficients of variation of 2+ concentration or incubation with the calcimimetic compound NPS R-467 markedly increased calcitonin secretion. Plasma calcitonin levels were elevated in rats anesthetized with ketamine/xylazine and in conscious rats with chronic renal insufficiency. Calcitonin levels decreased following EGTA- induced hypocalcemia and were undetectable after thyroparathyroidectomy. In normal conscious rats, plasma calcitonin levels averaged 3-5 pg/mL and increased up to 100-fold following calcium (Ca) infusion or NPS R-467 administration. The assay also quantified calcitonin in plasma of normal and Ca-injected mice. This assay has revealed that plasma calcitonin levels in normal rats are much lower than the detection limits of most existing assays, but can increase by 100-fold on activation of the C-cell Ca 2+ receptor.

KW - Calcimimetics

KW - Calcitonin

KW - Immunoradiometric assay

KW - Rat

KW - Rat medullary thyroid carcinoma 44-2 cells

UR - http://www.scopus.com/inward/record.url?scp=0032469139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032469139&partnerID=8YFLogxK

U2 - 10.1385/ENDO:9:3:293

DO - 10.1385/ENDO:9:3:293

M3 - Article

C2 - 10221596

AN - SCOPUS:0032469139

VL - 9

SP - 293

EP - 301

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 3

ER -